Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19.

Barbui T, De Stefano V, Alvarez-Larran A, Iurlo A, Masciulli A, Carobbio A, Ghirardi A, Ferrari A, Cancelli V, Elli EM, Andrade-Campos MM, Kabat MG, Kiladjian JJ, Palandri F, Benevolo G, Garcia-Gutierrez V, Fox ML, Foncillas MA, Morcillo CM, Rumi E, Osorio S, Papadopoulos P, Bonifacio M, Cervantes KSQ, Serrano MS, Carreno-Tarragona G, Sobas MA, Lunghi F, Patriarca A, Elorza BN, Angona A, Mazo EM, Koschmieder S, Carli G, Cuevas B, Hernandez-Boluda JC, Abadia EL, Cirici BX, Guglielmelli P, Garrote M, Cattaneo D, Daffini R, Cavalca F, Bellosillo B, Benajiba L, Curto-Garcia N, Bellini M, Betti S, Harrison C, Rambaldi A, Vannucchi AM

Open source

DOI: 10.1038/s41408-021-00417-3
Published: 2021 Feb 4
Container: Blood cancer journal
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41408-021-00417-3,
  title = {Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19.},
  author = {Barbui T and De Stefano V and Alvarez-Larran A and Iurlo A and Masciulli A and Carobbio A and Ghirardi A and Ferrari A and Cancelli V and Elli EM and Andrade-Campos MM and Kabat MG and Kiladjian JJ and Palandri F and Benevolo G and Garcia-Gutierrez V and Fox ML and Foncillas MA and Morcillo CM and Rumi E and Osorio S and Papadopoulos P and Bonifacio M and Cervantes KSQ and Serrano MS and Carreno-Tarragona G and Sobas MA and Lunghi F and Patriarca A and Elorza BN and Angona A and Mazo EM and Koschmieder S and Carli G and Cuevas B and Hernandez-Boluda JC and Abadia EL and Cirici BX and Guglielmelli P and Garrote M and Cattaneo D and Daffini R and Cavalca F and Bellosillo B and Benajiba L and Curto-Garcia N and Bellini M and Betti S and Harrison C and Rambaldi A and Vannucchi AM},
  year = {2021},
  journal = {Blood cancer journal},
  doi = {10.1038/s41408-021-00417-3},
  url = {https://doi.org/10.1038/s41408-021-00417-3}
}

RIS

TY  - JOUR
TI  - Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19.
AU  - Barbui T
AU  - De Stefano V
AU  - Alvarez-Larran A
AU  - Iurlo A
AU  - Masciulli A
AU  - Carobbio A
AU  - Ghirardi A
AU  - Ferrari A
AU  - Cancelli V
AU  - Elli EM
AU  - Andrade-Campos MM
AU  - Kabat MG
AU  - Kiladjian JJ
AU  - Palandri F
AU  - Benevolo G
AU  - Garcia-Gutierrez V
AU  - Fox ML
AU  - Foncillas MA
AU  - Morcillo CM
AU  - Rumi E
AU  - Osorio S
AU  - Papadopoulos P
AU  - Bonifacio M
AU  - Cervantes KSQ
AU  - Serrano MS
AU  - Carreno-Tarragona G
AU  - Sobas MA
AU  - Lunghi F
AU  - Patriarca A
AU  - Elorza BN
AU  - Angona A
AU  - Mazo EM
AU  - Koschmieder S
AU  - Carli G
AU  - Cuevas B
AU  - Hernandez-Boluda JC
AU  - Abadia EL
AU  - Cirici BX
AU  - Guglielmelli P
AU  - Garrote M
AU  - Cattaneo D
AU  - Daffini R
AU  - Cavalca F
AU  - Bellosillo B
AU  - Benajiba L
AU  - Curto-Garcia N
AU  - Bellini M
AU  - Betti S
AU  - Harrison C
AU  - Rambaldi A
AU  - Vannucchi AM
PY  - 2021
JO  - Blood cancer journal
DO  - 10.1038/s41408-021-00417-3
UR  - https://doi.org/10.1038/s41408-021-00417-3
ER  -

APA

T, B., V, D. S., A, A., A, I., A, M., A, C., A, G., A, F., V, C., EM, E., MM, A., MG, K., JJ, K., F, P., G, B., V, G., ML, F., MA, F., CM, M., E, R., S, O., P, P., M, B., KSQ, C., MS, S., G, C., MA, S., F, L., A, P., BN, E., A, A., EM, M., S, K., G, C., B, C., JC, H., EL, A., BX, C., P, G., M, G., D, C., R, D., F, C., B, B., L, B., N, C., M, B., S, B., C, H., A, R., & AM, V. (2021). Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19.. Blood cancer journal. https://doi.org/10.1038/s41408-021-00417-3

Source records

pubmed · retrieved 2026-09-26T22:43:01.051Z